| Authors: |
Bassil CF; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Dillon K; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Anderson GR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Mayro B; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Askin KN; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Winter PS; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Harry S; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Gruber S; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hall TM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hoj JP; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Cerda-Smith C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Hutchinson HM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Killarney ST; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Heffernan A; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Teddy C; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Singleton KR; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Qin L; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Jubien-Girard K; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France., Favreau C; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Robert G; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Tivon B; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., Livnah E; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., London N; Department of Chemical and Structural Biology, The Weizmann Institute of Science, Rehovot, Israel., Benhida R; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; Chemical & Biochemical Sciences Green-Process Engineering (CBS), Mohammed VI Polytechnic University, Benguerir, Morocco., Auberger P; Mediterranean Center for Molecular Medicine (C3M), Université Côte d'Azur, Nice, France., Pendergast AM; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA., Bar-Peled L; Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Charlestown, MA, USA., Lonard DM; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Martin AR; Institut de Chimie de Nice UMR-CNRS 7272, Université Nice Sophia Antipolis, Nice, France.; IBMM, University of Montpellier, CNRS ENSCM, Montpellier, France., Puissant A; INSERM UMR 944, IRSL, Saint-Louis Hospital, Paris Cité University, Paris, France., Wood KC; Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA. kris.wood@duke.edu. |
